{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:27:46Z","timestamp":1685536066246},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T00:00:00Z","timestamp":1357689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s11239-012-0860-1","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T17:34:49Z","timestamp":1357666489000},"page":"293-299","source":"Crossref","is-referenced-by-count":4,"title":["Increased local cytokine production at culprit superficial femoral artery plaques"],"prefix":"10.1007","volume":"36","author":[{"given":"Cameron W.","family":"Donaldson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Bertges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie E.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader Z.","family":"Elgharib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enkhtuyaa L.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taka","family":"Ashikaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold L.","family":"Dauerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,9]]},"reference":[{"issue":"4","key":"860_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1191\/1358863x03vm503oa","volume":"8","author":"A Silvestro","year":"2003","unstructured":"Silvestro A, Scopacasa F, Ruocco A, Oliva G, Schiano V, Zincarelli C, Brevetti G (2003) Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. Vasc Med 8(4):225\u2013232","journal-title":"Vasc Med"},{"issue":"1","key":"860_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2006.01.045","volume":"98","author":"EZ Fisman","year":"2006","unstructured":"Fisman EZ, Benderly M, Esper RJ, Behar S, Boyko V, Adler Y, Tanne D, Matas Z, Tenenbaum A (2006) Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and\/or healed myocardial infarction. Am J Cardiol 98(1):14\u201318","journal-title":"Am J Cardiol"},{"issue":"5","key":"860_CR3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.thromres.2005.10.012","volume":"118","author":"WJ Lee","year":"2006","unstructured":"Lee WJ, Sheu WH, Chen YT, Liu TJ, Liang KW, Ting CT, Lee WL (2006) Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases. Thromb Res 118(5):619\u2013626","journal-title":"Thromb Res"},{"issue":"1","key":"860_CR4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.amjcard.2003.09.003","volume":"93","author":"A Aggarwal","year":"2004","unstructured":"Aggarwal A, Schneider DJ, Terrien EF, Sobel BE, Dauerman HL (2004) Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques. Am J Cardiol 93(1):6\u20139","journal-title":"Am J Cardiol"},{"issue":"2","key":"860_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2005.11.027","volume":"187","author":"AV Meru","year":"2006","unstructured":"Meru AV, Mittra S, Thyagarajan B, Chugh A (2006) Intermittent claudication: an overview. Atherosclerosis 187(2):221\u2013237","journal-title":"Atherosclerosis"},{"issue":"11","key":"860_CR6","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0002-9149(03)00327-8","volume":"91","author":"A Aggarwal","year":"2003","unstructured":"Aggarwal A, Schneider DJ, Terrien EF, Terrien CM Jr, Sobel BE, Dauerman HL (2003) Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting. Am J Cardiol 91(11):1346\u20131349","journal-title":"Am J Cardiol"},{"issue":"8","key":"860_CR7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0002-9149(03)00971-8","volume":"92","author":"A Aggarwal","year":"2003","unstructured":"Aggarwal A, Schneider DJ, Sobel BE, Dauerman HL (2003) Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting. Am J Cardiol 92(8):924\u2013929","journal-title":"Am J Cardiol"},{"issue":"8","key":"860_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00019501-200412000-00003","volume":"15","author":"A Aggarwal","year":"2004","unstructured":"Aggarwal A, Blum A, Schneider DJ, Sobel BE, Dauerman HL (2004) Soluble CD40 ligand is an early initiator of inflammation after coronary intervention. Coron Artery Dis 15(8):471\u2013475","journal-title":"Coron Artery Dis"},{"issue":"1","key":"860_CR9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.atherosclerosis.2010.07.044","volume":"213","author":"T Yoshioka","year":"2010","unstructured":"Yoshioka T, Funayama H, Hoshino H, Nakamura T, Sugawara Y, Kubo N, Nagata O, Ako J, Ishikawa SE, Kawakami M, Momomura S (2010) Association of CD40 ligand levels in the culprit coronary arteries with subsequent prognosis of acute myocardial infarction. Atherosclerosis 213(1):268\u2013272","journal-title":"Atherosclerosis"},{"issue":"3","key":"860_CR10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2362.2007.01919.x","volume":"38","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Kusuyama T, Sato R, Yokota Y, Tsunoda F, Sato T, Shoji M, Iso Y, Koba S, Katagiri T (2008) Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction. Eur J Clin Investig 38(3):166\u2013173","journal-title":"Eur J Clin Investig"},{"issue":"5","key":"860_CR11","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ahj.2011.01.017","volume":"161","author":"JS Berger","year":"2011","unstructured":"Berger JS, Ballantyne CM, Davidson MH, Johnson JL, Tarka EA, Lawrence D, Trivedi T, Zalewski A, Mohler ER (2011) Peripheral artery disease, biomarkers, and darapladib. Am Heart J 161(5):972\u2013978","journal-title":"Am Heart J"},{"issue":"2","key":"860_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ahj.2004.09.032","volume":"150","author":"MM McDermott","year":"2005","unstructured":"McDermott MM, Guralnik JM, Corsi A, Albay M, Macchi C, Bandinelli S, Ferrucci L (2005) Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 150(2):276\u2013281","journal-title":"Am Heart J"},{"issue":"6","key":"860_CR13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.107.719369","volume":"117","author":"AD Pradhan","year":"2008","unstructured":"Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM (2008) Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation 117(6):823\u2013831","journal-title":"Circulation"},{"issue":"3","key":"860_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ahj.2007.04.060","volume":"154","author":"A Shankar","year":"2007","unstructured":"Shankar A, Li J, Nieto FJ, Klein BE, Klein R (2007) Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J 154(3):495\u2013501","journal-title":"Am Heart J"},{"issue":"1","key":"860_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9150(99)00013-1","volume":"145","author":"N Fiotti","year":"1999","unstructured":"Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, Dobrina A, Guarnieri G (1999) Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 145(1):51\u201360","journal-title":"Atherosclerosis"},{"issue":"2","key":"860_CR16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clim.2005.08.004","volume":"117","author":"L Marnell","year":"2005","unstructured":"Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117(2):104\u2013111","journal-title":"Clin Immunol"},{"issue":"1","key":"860_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2011.05.062","volume":"152","author":"L Forte","year":"2011","unstructured":"Forte L, Cimmino G, Loffredo F, De Palma R, Abbate G, Calabr\u00f2 P, Ingrosso D, Galletti P, Carangio C, Casillo B, Calabr\u00f2 R, Golino P (2011) C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. Int J Cardiol 152(1):7\u201312","journal-title":"Int J Cardiol"},{"issue":"11","key":"860_CR18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0338","volume":"2","author":"N Nishimoto","year":"2006","unstructured":"Nishimoto N, Kishimoto T (2006) Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2(11):619\u2013626","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"7","key":"860_CR19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.104.513085","volume":"112","author":"I Tzoulaki","year":"2005","unstructured":"Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG (2005) C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112(7):976\u2013983","journal-title":"Circulation"},{"issue":"1","key":"860_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2005.10.005","volume":"112","author":"YG Ko","year":"2006","unstructured":"Ko YG, Jung JH, Park S, Choi E, Joung B, Hwang KC, Ha JW, Choi D, Jang Y, Chung N, Shim WH, Cho SY (2006) Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction. Int J Cardiol 112(1):66\u201371","journal-title":"Int J Cardiol"},{"issue":"8","key":"860_CR21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","volume":"106","author":"P Andr\u00e9","year":"2002","unstructured":"Andr\u00e9 P, Nannizzi-Alaimo L, Prasad SK, Phillips DR (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106(8):896\u2013899","journal-title":"Circulation"},{"issue":"6667","key":"860_CR22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","volume":"391","author":"V Henn","year":"1998","unstructured":"Henn V, Slupsky JR, Gr\u00e4fe M, Anagnostopoulos I, F\u00f6rster R, M\u00fcller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391(6667):591\u2013594","journal-title":"Nature"},{"issue":"3","key":"860_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jlb.63.3.373","volume":"63","author":"DL Miller","year":"1998","unstructured":"Miller DL, Yaron R, Yellin MJ (1998) CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J Leukoc Biol 63(3):373\u2013379","journal-title":"J Leukoc Biol"},{"issue":"4","key":"860_CR24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02256091","volume":"11","author":"Y Xu","year":"2004","unstructured":"Xu Y, Song G (2004) The role of CD40-CD154 interaction in cell immunoregulation. J Biomed Sci 11(4):426\u2013438","journal-title":"J Biomed Sci"},{"issue":"3","key":"860_CR25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2567.1998.00520.x","volume":"94","author":"M Worm","year":"1998","unstructured":"Worm M, Ebermayer K, Henz B (1998) Lymphotoxin-alpha is an important autocrine factor for CD40\u00a0+\u00a0interleukin-4-mediated B-cell activation in normal and atopic donors. Immunology 94(3):395\u2013402","journal-title":"Immunology"},{"key":"860_CR26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1749-6632.2009.04747.x","volume":"1173","author":"JR Batuca","year":"2009","unstructured":"Batuca JR, Amaral MC, Alves JD (2009) Humoral mechanisms of atherogenesis. Ann N Y Acad Sci 1173:401\u2013408","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"860_CR27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.0000153810.81187.7D","volume":"111","author":"V Sanguigni","year":"2005","unstructured":"Sanguigni V, Pignatelli P, Lenti L, Ferro D, Bellia A, Carnevale R, Tesauro M, Sorge R, Lauro R, Violi F (2005) Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation 111(4):412\u2013419","journal-title":"Circulation"},{"issue":"5","key":"860_CR28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.thromres.2009.06.021","volume":"125","author":"M Pastuszczak","year":"2010","unstructured":"Pastuszczak M, Kotlarz A, Mostowik M, Zalewski J, Zmudka K, Undas A (2010) Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction. Thromb Res 125(5):382\u2013386","journal-title":"Thromb Res"},{"issue":"1","key":"860_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ahj.2005.10.006","volume":"151","author":"HF Alber","year":"2006","unstructured":"Alber HF, Frick M, Suessenbacher A, Doerler J, Schirmer M, Stocker EM, Dichtl W, Pachinger O, Weidinger F (2006) Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease\u2014a randomized, placebo-controlled study. Am Heart J 151(1):139","journal-title":"Am Heart J"},{"key":"860_CR30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amjcard.2005.09.101","volume":"5","author":"CS Chu","year":"2006","unstructured":"Chu CS, Lee KT, Lee MY, Su HM, Voon WC, Sheu SH, Lai WT (2006) Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Am J Cardiol 5:646\u2013650","journal-title":"Am J Cardiol"},{"issue":"1","key":"860_CR31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2006.01.021","volume":"190","author":"SH Han","year":"2007","unstructured":"Han SH, Koh KK, Quon MJ, Lee Y, Shin EK (2007) The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients. Atherosclerosis 190(1):205\u2013211","journal-title":"Atherosclerosis"},{"issue":"2","key":"860_CR32","doi-asserted-by":"crossref","first-page":"521.e1","DOI":"10.1016\/j.ahj.2005.10.021","volume":"151","author":"RR Azar","year":"2006","unstructured":"Azar RR, Kassab R, Zoghbi A, Aboujaoud\u00e9 S, El-Osta H, Ghorra P, Germanos M, Salam\u00e9 E (2006) Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease. Am Heart J 151(2):521.e1\u2013521.e4","journal-title":"Am Heart J"},{"issue":"2","key":"860_CR33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0735-1097(97)00510-X","volume":"31","author":"MI Furman","year":"1998","unstructured":"Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31(2):352\u2013358","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0860-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-012-0860-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0860-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T02:42:27Z","timestamp":1562553747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-012-0860-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1007\/s11239-012-0860-1","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,9]]}}}